The Trump administration’s 2020 budget includes more than two dozen recommendations for lowering prescription drug prices, including new ideas to punish drug makers for pay-for-delay settlements and to prohibit companies from using authorized generics to game Medicaid rebates. The administration also brought back some ideas with Democratic support, including capping seniors’ out-of-pockets costs and limiting Medicare Part B doctor pay increases for administering drugs to the rate of inflation. Pay-for-Delay While lawmakers increasingly support legislation banning settlements between brand-...